Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsA lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.
An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.
1.
The hidden costs of cancer for young survivors are derailing their financial futures
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
According to new studies, some cancer patients can safely forego radiation therapy.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
1.
The Benefits of Understanding Haptoglobin High: What You Need to Know
2.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
3.
Hypercoagulable State: Factors that Contribute to Blood Clots
4.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
5.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge